| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |